Skip to content
HowShorted

Accendra Health, Inc. short interest in 2021

In 2021, Accendra Health, Inc.'s disclosed short interest ran from 8.61% of shares outstanding on 15 Jan 2021 to 7.63% on 31 Dec 2021, a change of -0.98 percentage points. The year's high was 9.18% on 15 Oct 2021 and its low 6.50% on 31 Mar 2021, averaging 7.67% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.15 days on 29 Oct 2021. Full history: Accendra Health, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025

Aggregate net short position time series for Accendra Health, Inc. in 2021

2021 in figures

Start of year
8.61% (15 Jan 2021)
End of year
7.63% (31 Dec 2021)
Change
-0.98 pp
High
9.18% (15 Oct 2021)
Low
6.50% (31 Mar 2021)
Average
7.67%
Highest days to cover
13.15 (29 Oct 2021)
SEC filings marked
8

Every report in 2021

Accendra Health, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20218.61%5.92
29 Jan 20217.61%4.66
12 Feb 20217.19%6.25
26 Feb 20217.54%2.4710-K filed, results (8-K)
15 Mar 20217.39%4.40
31 Mar 20216.50%5.49
15 Apr 20216.99%9.37
30 Apr 20216.52%6.80
14 May 20217.83%6.1810-Q filed, results (8-K)
28 May 20218.61%2.76
15 Jun 20217.12%4.79
30 Jun 20217.01%4.04
15 Jul 20217.32%7.07
30 Jul 20216.58%6.57
13 Aug 20216.86%4.6110-Q filed, results (8-K)
31 Aug 20217.14%11.06
15 Sep 20218.44%9.18
30 Sep 20219.01%5.83
15 Oct 20219.18%10.31
29 Oct 20219.09%13.15
15 Nov 20218.34%6.4910-Q filed, results (8-K)
30 Nov 20217.60%11.19
15 Dec 20217.93%11.48
31 Dec 20217.63%8.62

See also: Accendra Health, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.